维持性血液透析患者早期死亡原因及危险因素的配对研究
[The study of cause of early death and a matched study for the risk factors in patients undergoing maintenance hemodialysis].
作者信息
Hua Jincheng, Liang Meng, Shen Shuqiong, Li Caifeng, Xu Shugen
机构信息
The 174th People's Liberation Army Hospital of Anhui Medical University, Xiamen 361000, Fujian, China. Corresponding author: Xu Shugen, Email:
出版信息
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 May;27(5):354-8. doi: 10.3760/cma.j.issn.2095-4352.2015.05.007.
OBJECTIVE
To explore the cause of early death (death within 3-12 months after hemodialysis) and the related influencing factors patients undergoing maintenance hemodialysis (MHD) as to provide a scientific basis for the prevention of early death.
METHODS
A retrospective matched controlled study was conducted. Fifty-one patients who underwent MHD from January 2004 to April 2014 and died within 3-12 months after hemodialysis in hemodialysis center of the 174th Chinese People's Liberation Army Hospital were included in the case group by retrospective analysis method. According to 1:2 matched controls, 102 patients underwent hemodialysis in the same period (±2 months) and survived over 12 months were selected as control group. All patients received regular hemodialysis (dialysis 2-3 times per week), with conventional limitation of water and sodium intake, routine treatments such as control of blood pressure, treatment of anemia and disorders of calcium and phosphorus contents. Causes of short-term death were analyzed. Clinical and biochemical parameters of two groups were collected when dialysis was started, and the single factor and multiple factors logistic regression was used to analyze the related risk factors when dialysis was started. Receiver operating characteristic curve (ROC) was plotted to evaluate the value of above parameters in predicting the early death in patents with MHD.
RESULTS
The main causes of early death of 51 patients with MHD were mainly cardiovascular and cerebrovascular diseases (27 cases, 52.9%), and infections (15 cases, 29.4%). It was shown by single factor analysis that the age [odds ratio (OR) = 6.625, 95% confidence interval (95%CI) = 3.232-13.580, P = 0.000 ], diabetes (OR = 3.875, 95%CI = 0.654 - 10.622, P = 0.031), specialist intervention time before dialysis (OR = 0.349, 95%CI = 0.287 - 0.572, P = 0.004), the emergence of cardiovascular and cerebrovascular events before dialysis (OR = 9.667, 95%CI = 4.632 - 20.174, P = 0.000), the first dialysis for emergency dialysis (OR = 3.875, 95%CI = 1.713 - 8.765, P = 0.005), blood albumin level (OR = 0.294, 95%CI = 0.068 - 0.550, P = 0.008), leukocyte count (OR = 6.286, 95%CI = 1.648 - 23.982, P = 0.026), neutrophil count (OR = 2.833, 95%CI = 1.630 - 4.923, P = 0.001) might be the factors correlating with early death. Eight independent factors were statistically significant, and their effect on the MHD patients was analyzed by logistic regression analysis in α = 0.05 level. The results showed that patients with old age (OR = 1.054, 95%CI = 1.019-1.090, P = 0.002), and the emergence of cardio-cerebrovascular events (OR = 7.469, 95%CI = 2.474 - 22.545, P = 0.000) were early death risk factors of MHD patients, and early specialist intervention before dialysis was a protective factor (OR = 0.286, 95%CI = 0.113-0.722, P = 0.008). ROC curve showed that age had moderate diagnostic value for early death of MHD [area under ROC curve (AUC) = 0.756], the cut-off value was 59.0 years old, the sensitivity was 66.7%, and the specificity was 77.5%. The diagnostic value of early specialist intervention before dialysis was relatively low (AUC = 0.36), the cut-off value was 0.875 years, the sensitivity was 39.2%, and the specificity was 33.3%.
CONCLUSIONS
Old age, the emergency of cardiovascular and cerebrovascular events before dialysis is associated with early death, and specialist intervention ahead of dialysis can reduce the risk of early death.
目的
探讨维持性血液透析(MHD)患者早期死亡(血液透析后3 - 12个月内死亡)的原因及相关影响因素,为预防早期死亡提供科学依据。
方法
进行一项回顾性匹配对照研究。采用回顾性分析方法,将2004年1月至2014年4月在解放军第174医院血液透析中心进行MHD且在血液透析后3 - 12个月内死亡的51例患者纳入病例组。按照1:2匹配对照,选取同期(±2个月)进行血液透析且存活超过12个月的102例患者作为对照组。所有患者均接受规律血液透析(每周透析2 - 3次),常规限制水钠摄入,进行控制血压、治疗贫血及钙磷代谢紊乱等常规治疗。分析短期死亡原因。透析开始时收集两组患者的临床和生化参数,采用单因素及多因素logistic回归分析透析开始时的相关危险因素。绘制受试者工作特征曲线(ROC)以评估上述参数对MHD患者早期死亡的预测价值。
结果
51例MHD患者早期死亡的主要原因主要是心脑血管疾病(27例,52.9%)和感染(15例,29.4%)。单因素分析显示,年龄[比值比(OR)= 6.625,95%置信区间(95%CI)= 3.232 - 13.580,P = 0.000]、糖尿病(OR = 3.875,95%CI = 0.654 - 10.622,P = 0.031)、透析前专科干预时间(OR = 0.349,95%CI = 0.287 - 0.572,P = 0.004)、透析前出现心脑血管事件(OR = 9.667,95%CI = 4.632 - 20.174,P = 0.000)、首次透析为急诊透析(OR = 3.875,95%CI = 1.713 - 8.765,P = 0.005)、血白蛋白水平(OR = 0.294,95%CI = 0.068 - 0.550,P = 0.008)、白细胞计数(OR = 6.286,95%CI = 1.648 - 23.982,P = 0.026)、中性粒细胞计数(OR = 2.833,95%CI = 1.630 - 4.923,P = 0.001)可能是与早期死亡相关的因素。8个独立因素差异有统计学意义,在α = 0.05水平采用logistic回归分析其对MHD患者的影响。结果显示,高龄患者(OR = 1.054,95%CI = 1.019 - 1.090,P = 0.002)及透析前出现心脑血管事件(OR = 7.469,95%CI = 2.474 - 22.545,P = 0.000)是MHD患者早期死亡的危险因素,透析前早期专科干预是保护因素(OR = 0.286,95%CI = 0.113 - 0.722,P = 0.008)。ROC曲线显示,年龄对MHD早期死亡有中等诊断价值[ROC曲线下面积(AUC)= 0.756],截断值为59.0岁,灵敏度为66.7%;特异性为77.5%。透析前早期专科干预的诊断价值相对较低(AUC = 0.36),截断值为0.875年,灵敏度为39.2%,特异性为33.3%。
结论
高龄、透析前出现心脑血管急症与早期死亡相关,透析前专科干预可降低早期死亡风险。